Dr Harendra Parekh

Researcher biography
Harendra's research interests span pharmaceutical medicinal chemistry and pharmaceutics as applied to innovative formulation & device co-development, and advanced non-viral, bioresponsive drug/gene delivery system design, synthesis and evaluation. His team at the School of Pharmacy & Pharmaceutical Sciences have been instrumental in developing highly innovative and versatile platform delivery systems: for direct, nose-to-brain delivery of therapeutics with their Sol-Gel platform; a US-patented bioresponsive linker technology for stabilisation of peptide therapeutics in their natural conformation, transforming endogenous molecules into safe & effective medicines; engineering bioresponsive lipid nanoparticles (bLNPs) with tissue targeting and a unique gene 'catch-&-release' feature; micro- & nanobubble formulations, which when used in-conjuction with ultrasound, pave the way for improved rates of 'on-demand' drug delivery and release in target tissue e.g. for ocular indications. Harendra actively engages with pharma industry executives, and investors, globally, to showcase his array of disruptive platforms designed with clinical translation front and centre of all research endeavours.
BScPharm(Hon I), PhD (Nottingham)
Harendra completed his BSc in pharmacy (UK) and registered as a Pharmacist in 1998. He went onto undertake his PhD in Medicinal Chemistry at the University of Nottingham in the same year. Under the supervision of Dr B. Kellam and Dr. S. R. Chhabra he investigated the development of novel linkers for solid phase peptide and glycopeptide synthesis. Harendra was awarded his PhD in 2002, and after a short time working in community pharmacy in the UK relocated to Australia and took up a position as research officer in the School of Chemistry at UQ. He continues to be a member of the Royal Pharmaceutical Society of GB and is also registered with the AHPRA (pharmacist) in QLD.
Dr Parekh was appointed to a teaching and research role in the School of Pharmacy & Pharmaceutical Sciences in 2005. He is Scientific Founder & Chief Research Officer of two start-up companies that hold his platform technologies at their core (www.preveceutical.com; www.biogenetherapeutics.com). He also holds an adjunct-Faculty position at Manipal College of Pharmaceutical Sciences, Manipal University (India).